fashion -WSS

fashion

author：hotspot 2025-09-30 12:10:48 - browse：579

Sammy Kimball for STAT

Who’s watching the drug price watchmen? Are RSV vaccines too expensive? And is it finally time for Novavax to shine?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Bob Herman joins us to explain his year-long investigation into some brazen conflicts of interest in the world of prescription drug pricing. Then, STAT’s Helen Branswell calls in to walk us through a news-packed week for vaccines, including weighty decisions for Covid-19 and RSV.

For more on what we cover, here’s the story on conflicts of interest; here’s the latest on RSV vaccines; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Artificial intelligence use in health care faces greater scrutiny in 2024

hotspot

WSS

Why don't Americans have at

Congress might make insulin pumps more accessible to the blind

MD Anderson's Padmanee Sharma responds to research credit suit

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Secretariat’s lessons for human medicine

AMAs digital advisors table RPM coding reform proposal, again

focus

fashion

Wikipedia

Hollywood unions extend contract negotiations for actors

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Having children helps parents live longer, especially after age 80

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Trump demands the U.S. pay no more for drugs than other countries … again

Resistance to opioid

Walensky prepares to leave CDC — and Congress — behind

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

entertainment

ACIP vaccine advisory panel sees its vacancies filled

Abbott's new heart device gets FDA advisory panel nod

Weight loss drugs aren’t covered by Obamacare. That may change

Too many hospitalized Covid

AMAs digital advisors table RPM coding reform proposal, again

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

explore

hotspot

hotspot

leisure time